× Stakeholders’ Perceived Barriers and Successes of Quality Improvement Programs for Patients With Diabetes Comment on “Quality and Performance Measurement in Primary Diabetes Care: A Qualitative Study in Urban China”

× Negotiating Medical Insurance Drug Prices: The Role in Reducing Costs of Orphan Drugs for Rare Diseases

× What Are Healthy Societies? A Thematic Analysis of Relevant Conceptual Frameworks

× New Zealand Pae Ora Healthcare Reforms 2022: Viable by Design? A Qualitative Study Using the Viable System Model

× Implementation of Medicines Pricing Policies in Ghana: The Interplay of Policy Content, Actors’ Participation, and Context

× How to Design Integrated Strategies to Improve Healthcare Quality Whilst Containing Healthcare Costs? A Response to the Recent Commentaries

× Doing Health Policy Analysis: The Enduring Relevance of Simple Models Comment on “Modelling the Health Policy Process: One Size Fits All or Horses for Courses”

× Economic Sanctions Affecting Household Food and Nutrition Security and Policies to Cope With Them: A Systematic Review

× Political and Governance Challenges to Achieving Global HIV Goals with Injecting Drug Users: The Case of Pakistan

× Preferential Tax Policies: An Invisible Hand behind Preparedness for Public Health Emergencies